cota-logo-wht-rgb
Contact Us
cota-logo-wht-rgb

Clarity in cancer care delivery

The insights hidden within your data can be uncovered
to illuminate a path to better cancer care

Oncology Provider Solutions

COTA’s data curation service and oncology analytics solution help oncology practices and cancer centers make sense of fragmented and often incomplete EHR data. Our award winning Real World Analytics solution (RWA) helps clinicians and researchers answer complex questions and gain insight into their institution’s patient population, treatment patterns and disease outcomes to bring clarity to cancer care.

#6846 - COTA Healthcare homepage redesign - Unlock Real-World Data

Unlock Real-World Data

Unlock the potential of your clinical data through our expert technology-enabled, disease specific, longitudinal patient record curation.​

#6846 - COTA Healthcare homepage redesign - Highly Intuitive Analytics

Highly Intuitive Analytics

Administrators gain direct access to clinically relevant metrics and reporting, eliminating the need for onsite technology support.

#6846 - COTA Healthcare homepage redesign - Compare Cohorts

Compare Cohorts

View clinically similar patient cohorts side-by-side to understand differences in care and outcomes.

#6846 - COTA Healthcare homepage redesign - Analyze Outcomes

Analyze Outcomes

Understand real world outcomes within your patient population.

#6846 - COTA Healthcare homepage redesign - Identify Treatment Patterns

Identify Treatment Patterns

Gain insight into variations in care delivery. Understand the consistency of care among your physicians and across locations.

#6846 - COTA Healthcare homepage redesign - Track Key Metrics

Track Key Metrics

Track widely accepted oncology care standards with the option to create custom metrics for your institution.

Real World Analytics by COTA

cota-provider-video-preview

Advancing Research

COTA customers have unique access to our deeply curated and continually growing database of deidentified and contemporaneous patient data across 14 cancer types, with expansion to 5 additional cancer types by the end of the year. Our partners can leverage the individual datasets on an ad-hoc basis, and additionally explore broader access as a member of our newly-formed COTA Research Consortium — a cooperative network of NCI-designated Cancer Centers. As a member of the Research Consortium, centers will partner to develop research protocols to further advance the knowledge, understanding and use of RWD.

Latest Resources

It’s Not All about the Benjamins – Other Hurdles Presented by Research Participation, and why Payment won’t Resolve Them

C.K. Wang discusses payment for research participation in this exploratory workshop hosted by the Office for Human Research Protections in the U.S. Department of Health & Human Services.
read more

Real-World Evidence is Now a “True End-to-End Capability” for Life Science Companies, Says Deloitte

Deloitte’s new Real-World Evidence Survey reveals that life sciences companies are now using real-world data (RWD) and real-world evidence (RWE) throughout the product life cycle—from early discovery through commercialization.
read more

Using Real-World Data in Blood Cancer Research with Paul Barr, MD

Blood cancers make up more than 100 different diagnoses in the current classification system. And there are three main groups of blood cancer: leukemia, lymphoma, and myeloma. One of the most common leukemias in adults is chronic lymphocytic leukemia (CLL). In this episode of Real World Talk, our host Ming He welcomes Paul Barr, MD, the medical director of the Clinical Trials Office of the Wilmot Cancer Institute. They talk about the importance of Blood Cancer Awareness Month, the development of CLL treatments, and the potential use of real-world data in blood cancer research.
listen now
"In my opinion, COTA now has what is the single best analytic tool in the market for monitoring practice patterns and quality in oncology."
"Working with COTA has enabled us to have clear and accurate access to understanding patterns of patient care faster than we've ever had."
“Proving your value as a provider is a matter of wedding your outcomes and costs. Through our work with COTA, we're closer to being able to do this than we ever have been before."
"The goal is to standardize care. Standardization is essential to patient safety and the control of costs. COTA's unique capabilities and partnership model enable us, for the first time, to monitor this standardization efficiently."

Getting Focused

Our approach makes sense of all the relevant aspects of the patient journey from your medical records – data in physician notes, pathology, radiology, surgical reports, genomic testing results and to develop a longitudinal patient record and comprehensive picture of care.
COTA maintains a highly sophisticated and multidisciplinary data curation approach. Our methodology was developed by oncologists with input from a team of informaticists, cancer outcomes researchers, and biostatisticians with the goal of unlocking data from both structured and unstructured sources. All of our data curation efforts occur on the COTA Abstraction Platform (CAP), which is an internally developed and proprietary platform that enables COTA to leverage technology as we scale our curation efforts. Data elements are standardized across sources and ontologies to create a single, structured dataset that covers the full longitudinal history of a patient’s clinical care. COTA’s extensive quality control and audit process ensures the data can be readily transformed into fit-for-purpose research grade datasets and occurs at every step in the curation process, from the point of data entry all the way through to data delivery. Additionally, our process includes inter-rater reliability scoring prior to abstraction as well as programmatic controls which detect clinical improbability at data ingestion. COTA can curate on-demand, longitudinal histories of your patient population to meet the full range of research and operational improvement interests at your center.
Our easy-to-use data visualization tools display your data in the clearest, most impactful way. Data is also available in a variety of file formats to suit your preferences for additional data analysis.
Our data lets you look deeply at performance and outcomes across your provider organization, so you can identify variation and take action to improve care quality and outcomes.
Our numerical classification system clusters patients with clinically similar disease characteristics, so that you gain a clearer, fuller picture, and uncover insights that could impact treatment decisions and outcomes.

Let’s work together to transform cancer care.

REQUEST A DEMO

Bringing clarity to cancer

We are working to ensure that everyone touched by cancer has a clear path to the right care.

Privacy Policy

Terms of Use

CCPA Privacy Notice

Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry
  • This field is for validation purposes and should be left unchanged.